Global Intestinal Pseudo-Obstruction Treatment Market Overview 2033 : Forecasted Market Size And Growth Rate | F. Hoffmann-La Roche AG, Merck Sharp & Dohme Corp, Bayer AG, Sanofi S.A., AstraZeneca PLC, GSK PLC

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Intestinal Pseudo-Obstruction Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $29.04 billion In 2028 At A CAGR Of 5.5% :

The intestinal pseudo-obstruction treatment market size has grown strongly in recent years. It will grow from $22.06 billion in 2023 to $23.46 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increased recognition and diagnosis, advancements in medical imaging, advancements in gastrointestinal motility testing, global healthcare access.

The intestinal pseudo-obstruction treatment market size is expected to see strong growth in the next few years. It will grow to $29.04 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to research and drug development, telemedicine and remote monitoring, patient education and support, reimbursement policies. Major trends in the forecast period include advanced gastrointestinal motility testing, immunomodulatory therapies, nutritional interventions, data analytics and ai.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12995&type=smp

Intestinal Pseudo-Obstruction Treatment Market Major Segments
The intestinal pseudo-obstruction treatment market covered in this report is segmented -

1) By Drug Class: Antibiotics; Antidepressants; Antidiarrheals
2) By Treatment: Medication; Surgery; Diet; Decompression; Other Treatments
3) By Route Of Administration: Oral; Intravenous; Other Route Of Administrations
4) By Diagnosis: Physical Examination; Biopsy; Blood Test; Gastric Emptying Tests; Imaging Tests; Other Diagnosis
5) By End User: Clinic; Hospitals; Other End Users

Key Driver - Parkinson's Disease-Associated Gastrointestinal Issues Boost Intestinal Pseudo-Obstruction Treatment Market

The rising cases of Parkinson's disease are expected to propel the growth of the intestinal pseudo-obstruction treatment market going forward. Parkinson's disease refers to a neurodegenerative condition that primarily affects the dopamine-producing neurons in the substantia nigra, a particular region of the brain. There is an increased incidence of IPO in individuals with Parkinson's disease because it affects the enteric nervous system, causing gastrointestinal dysmotility that can result in megacolon or intestinal blockage, including acute colonic pseudo-obstruction. For instance, in December 2022, according to the Parkinson's Foundation, a US-based non-profit group, Parkinson's disease (PD) was identified in roughly 90,000 Americans annually, compared to the previous estimate of 60,000 diagnoses annually, there has been a sharp 50% increase. In addition, it is predicted that by 2030, there will be 1.2 million people worldwide with Parkinson's disease. Therefore, the rising cases of Parkinson's disease drive the growth of the intestinal pseudo-obstruction treatment market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12995&type=smp

Prominent Trend - Pharmaceutical Innovations Embrace Plant-Based Solutions For Intestinal Pseudo-Obstruction Treatment

Major companies operating in the intestinal pseudo-obstruction treatment market are integrating their efforts into adopting new solutions towards plant-based solution to sustain their position in the market. Plant-based supplements can help reduce the risk of bowel obstruction by promoting regular bowel movements and reducing inflammation. For instance, in August 2021, Enzymedica Inc., a US-based pharmaceutical company, launched Gut Motility, a new plant-based supplement to promote healthier gastrointestinal motility and gastric emptying. It is a first-of-its-kind nutraceutical formulation designed to address problems with digestive transit and stomach emptying that combines artichoke leaf extract, ginger root CO2 extract and apple cider vinegar. The main component of Gut Motility is ProDigest, a triple-standardized artichoke leaf extract and ginger root CO2 extract blend shown in clinical studies to assist good digestive transit. The mixture also has the unique addition of apple cider vinegar, made from apples grown in the United States, to support a balanced pH in the digestive tract and optimize metabolism.

Intestinal Pseudo-Obstruction Treatment Market Players
Major players in the intestinal pseudo-obstruction treatment market are F. Hoffmann-La Roche AG, Merck Sharp & Dohme Corp, Bayer AG, Sanofi S.A., AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Amgen PLC, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Mylan N.V., Biogen Inc., Penn Medicine, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Inc., Dr. Reddy's Laboratories Ltd., Allergan PLC, Torrent Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Melinta Therapeutics LLC, Tetraphase Pharmaceuticals Inc., Callisto Pharmaceuticals Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/intestinal-pseudo-obstruction-treatment-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the intestinal pseudo-obstruction treatment market in 2023. The regions covered in intestinal pseudo-obstruction (IPO) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Intestinal Pseudo-Obstruction Treatment Market Report Structure
3. Intestinal Pseudo-Obstruction Treatment Market Trends And Strategies
4. Intestinal Pseudo-Obstruction Treatment Market - Macro Economic Scenario
5. Intestinal Pseudo-Obstruction Treatment Market Size And Growth
…..
27. Intestinal Pseudo-Obstruction Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.